Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Nelson

Showing results (361-370 of 442) with videos related to

Pageof 45
Sort By:
Antiviral Therapy|August 6, 2011
Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patientsJoseph Gathe, Jaime Andrade-Villanueva, Steven Santiago, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 5, 2019
Correction: Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysisLei Zhang, Yining Bao, Moeen Riaz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 19, 2019
Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysisLei Zhang, Yining Bao, Moeen Riaz, et al.
American Heart Journal|October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocolClara K Chow, Emily R Atkins, Laurent Billot, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D studyMarianne Martinello, Sanjay Bhagani, David Shaw, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotypeAndrew D Revell, Dechao Wang, Robin Wood, et al.
European Journal of Cardiovascular Nursing|June 20, 2015
Impact of nurse-mediated management on achieving blood pressure goal levels in primary care: Insights from the Valsartan Intensified Primary carE Reduction of Blood Pressure StudyMelinda J Carrington, Garry L Jennings, Mark Harris, et al.
Plos Clinical Trials|July 28, 2006
A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard StudyMike Youle, Sean Emery, Martin Fisher, et al.
Heart, Lung & Circulation|June 1, 2020
Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ)Stephen J Nicholls, Mark Nelson, Carolyn Astley, et al.
AIDS (London, England)|September 20, 2017
Hepatitis B, hepatitis C, and mortality among HIV-positive individualsAlicia C Thornton, Sophie Jose, Sanjay Bhagani, et al.
Pageof 45

Showing results (361-370 of 442) with videos related to

Sort By:
Pageof 45
Antiviral Therapy|August 6, 2011
Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patientsJoseph Gathe, Jaime Andrade-Villanueva, Steven Santiago, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 5, 2019
Correction: Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysisLei Zhang, Yining Bao, Moeen Riaz, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 19, 2019
Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysisLei Zhang, Yining Bao, Moeen Riaz, et al.
American Heart Journal|October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocolClara K Chow, Emily R Atkins, Laurent Billot, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D studyMarianne Martinello, Sanjay Bhagani, David Shaw, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotypeAndrew D Revell, Dechao Wang, Robin Wood, et al.
European Journal of Cardiovascular Nursing|June 20, 2015
Impact of nurse-mediated management on achieving blood pressure goal levels in primary care: Insights from the Valsartan Intensified Primary carE Reduction of Blood Pressure StudyMelinda J Carrington, Garry L Jennings, Mark Harris, et al.
Plos Clinical Trials|July 28, 2006
A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard StudyMike Youle, Sean Emery, Martin Fisher, et al.
Heart, Lung & Circulation|June 1, 2020
Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ)Stephen J Nicholls, Mark Nelson, Carolyn Astley, et al.
AIDS (London, England)|September 20, 2017
Hepatitis B, hepatitis C, and mortality among HIV-positive individualsAlicia C Thornton, Sophie Jose, Sanjay Bhagani, et al.
Pageof 45